Page 117 - วารสารการแพทย์แผนไทย ปีที่ 21 ฉบับที่ 2
P. 117

J Thai Trad Alt Med                                   Vol. 21  No. 2  May-Aug  2023  333




            solution and reagents were prepared following   protocol, RNA was re-suspended in 30 µL of
            the procedure described in the manufacturer’s   nuclease-free water and the products ran on

            protocol.  The plant extracts were diluted with   agarose gels to check the quality of the RNA.
            water at the highest concentration, which was   cDNA was synthesized using QuantiTect Rev.
            not toxic to Calu-3 cells and then diluted to   Transcription Kit (Qiagen, Valencia, CA, USA)

            lower 2 concentrations. A Total of 30 µL of TM-  following the manufacturer’s protocol. Briefly,
            PRSS2 enzyme at a concentration of 5 ng/µL in   2-µg template RNA was added to the reverse-
            1x TMPRSS2 Assay Buffer was added to 10 µL   transcription master mix and then the samples

            of diluted extracts or 10 µM camostat standard   tubes were incubated at 42 ˚C for 15 min.  The
            inhibitor (the background and enzyme controls   cDNA samples were tested in triplicate with
            were also tested).  The mixed solutions were   quantitative PCR using a QuantiTect SYBR

            placed at room temperature for 30 min. A total   Green PCR Reagents kit (Qiagen, Valencia,
            of 10 µL of TMPRSS2 fluorogenic substrate   CA, USA). A teetotal of 2 µL of each sample

            mix (50 µM) was then added to all wells and   was mixed with SYBR Green PCR Master Mix
            placed at room temperature for 10 min whilst   and 10x QuantiTect Primers (Qiagen, Valencia,
            being protected from light. The plate was im-  CA, USA), then performed the real-time PCR

            mediately placed in a spectrofluorometer and   (RT-qPCR) followed the manufacturer’s pro-
            the fluorescent signal measured (Ex/Em =    tocol in Thermal cycler (PCR) (Analytik Jena

            383/455 nm) in kinetic mode for 30 min.  The   GmbH, Valencia, Jena, Germany).  mRNA ra-
            relative inhibition activity (%) of the sample   tios relative to the glyceraldehyde 3-phosphate
            was calculated using a relative fluorescence   dehydrogenase (GAPDH) housekeeping gene

            unit (RFU) compared to enzyme control.      were calculated for the standardization of gene
                 2.6  Gene expression using real‑time   expression levels. A melting curve analysis
            reverse‑transcription polymerase chain reac‑  was also performed to verify the specificity and

            tion (RT‑PCR)                               identity of PCR products.  For selected genes,
                                              5
                 Calu-3 cells were seeded at 5 5 10  cells/  the data were analyzed using the equation
                                                                                        [20]
            well in 6-well plates for 24 hours, then treated   described by Livak and Schmittgen  as fol-
            with the compounds or extracts at concen-   lows: the amount of target =2 − ∆∆Ct .  The average
            trations that were not toxic to the cells for 24   ∆Ct from the untreated cells is a calibrator for

            hours.  Total RNA of each sample was extract-  each gene tested. This assay was conducted
            ed using the RNeasy Mini Kit (Qiagen, Hilden,   at Toxicology laboratory, Medicinal Plant
            Germany).  According to the manufacturer’s   Research Institute, Department of Medical
   112   113   114   115   116   117   118   119   120   121   122